In the last 12 months, insiders at Annexon, Inc. ($ANNX) filed 120 transactions with the SEC: 22 open-market purchases totaling $9,072,300 and 41 sales totaling $841,284. Net insider sentiment: net buying.
Annexon, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Satter Muneer A (Not found) — 7 transactions totaling $8,655,784
- Yednock Ted (EVP & CHIEF INNOVATION OFFICER) — 21 transactions totaling $313,499
- Love Douglas (PRESIDENT AND CEO) — 11 transactions totaling $312,143
- Carson William H. (Not found) — 18 transactions totaling $278,246
- Choi Jung (Not found) — 3 transactions totaling $138,270
View all SEC Filings for Annexon, Inc. (ANNX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | Carson William H. | Not found | P | Common Stock | 8000 | $5.67 | 62,405.0000 | 149,123,701 | 14.70% | 0.01% |
| March 2, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 4339 | $5.42 | 182,625.0000 | 149,123,701 | 2.32% | 0.00% |
| March 2, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 5566 | $5.42 | 154,161.0000 | 149,123,701 | 3.48% | 0.00% |
| March 2, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 5565 | $5.42 | 170,700.0000 | 149,123,701 | 3.16% | 0.00% |
| March 2, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S | Common Stock | 5894 | $5.43 | 180,093.0000 | 149,123,701 | 3.17% | 0.00% |
| March 2, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S | Common Stock | 5820 | $5.43 | 123,582.0000 | 149,123,701 | 4.50% | 0.00% |
| Feb. 19, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 149,123,701 | 9999.99% | 0.17% |
| Feb. 19, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 149,123,701 | 9999.99% | 0.17% |
| Feb. 19, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 149,123,701 | 9999.99% | 0.17% |
| Feb. 19, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Common Stock | 62500 | $0.00 | 185,987.0000 | 149,123,701 | 50.61% | 0.04% |
| Feb. 19, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 149,123,701 | 9999.99% | 0.17% |
| Feb. 19, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Common Stock | 62500 | $0.00 | 159,727.0000 | 149,123,701 | 64.28% | 0.04% |
| Feb. 19, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 62500 | $0.00 | 176,265.0000 | 149,123,701 | 54.94% | 0.04% |
| Feb. 19, 2026 | Love Douglas | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 1250000 | $0.00 | 1,250,000.0000 | 149,123,701 | 9999.99% | 0.84% |
| Feb. 19, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Common Stock | 56250 | $0.00 | 129,402.0000 | 149,123,701 | 76.89% | 0.04% |
| Feb. 19, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 149,123,701 | 9999.99% | 0.15% |
| Feb. 19, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Common Stock | 62500 | $0.00 | 186,964.0000 | 149,123,701 | 50.22% | 0.04% |
| Feb. 18, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 7857 | $5.11 | 97,227.0000 | 149,123,701 | 7.48% | 0.01% |
| Feb. 18, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 6225 | $5.10 | 124,464.0000 | 149,123,701 | 4.76% | 0.00% |
| Feb. 18, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S | Common Stock | 5290 | $5.10 | 73,152.0000 | 149,123,701 | 6.74% | 0.00% |
| Feb. 18, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 7851 | $5.11 | 113,765.0000 | 149,123,701 | 6.46% | 0.01% |
| Feb. 18, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S | Common Stock | 5290 | $5.10 | 123,487.0000 | 149,123,701 | 4.11% | 0.00% |
| Dec. 30, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $5.02 | 54,405.0000 | 149,123,701 | 8.18% | 0.00% |
| Dec. 1, 2025 | Choi Jung | Not found | P | Common Stock | 33000 | $4.19 | 33,000.0000 | 149,123,701 | 9999.99% | 0.02% |
| Dec. 1, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $4.47 | 50,290.0000 | 149,123,701 | 8.91% | 0.00% |
| Nov. 21, 2025 | Satter Muneer A | Not found | P | Common Stock | 422613 | $4.28 | 9,728,637.0000 | 149,123,701 | 4.54% | 0.28% |
| Nov. 20, 2025 | Satter Muneer A | Not found | P | Common Stock | 400000 | $4.48 | 9,306,024.0000 | 149,123,701 | 4.49% | 0.27% |
| Nov. 19, 2025 | Satter Muneer A | Not found | P | Common Stock | 500000 | $3.94 | 8,906,024.0000 | 149,123,701 | 5.95% | 0.34% |
| Nov. 18, 2025 | Satter Muneer A | Not found | P | Common Stock | 500000 | $3.18 | 8,406,024.0000 | 149,123,701 | 6.32% | 0.34% |
| Nov. 17, 2025 | Satter Muneer A | Not found | P | Common Stock | 500000 | $2.99 | 7,906,024.0000 | 149,123,701 | 6.75% | 0.34% |
| Oct. 30, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $3.17 | 46,175.0000 | 149,123,701 | 9.78% | 0.00% |
| Sept. 30, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $3.05 | 42,060.0000 | 137,404,145 | 10.84% | 0.00% |
| Sept. 2, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $2.09 | 37,945.0000 | 137,404,145 | 12.16% | 0.00% |
| July 30, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $2.43 | 33,830.0000 | 137,404,145 | 13.85% | 0.00% |
| July 14, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 853 | $2.61 | 130,689.0000 | 137,404,145 | 0.65% | 0.00% |
| July 14, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1117 | $2.58 | 121,616.0000 | 137,404,145 | 0.91% | 0.00% |
| July 14, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 1116 | $2.58 | 105,084.0000 | 137,404,145 | 1.05% | 0.00% |
| June 30, 2025 | Carson William H. | Not found | P | Common Stock | 4115 | $2.46 | 29,715.0000 | 137,404,145 | 16.07% | 0.00% |
| June 5, 2025 | Waddill William D. | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | Carson William H. | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | Satter Muneer A | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | Choi Jung | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | WIGGANS THOMAS G | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | JONES WILLIAM A JR | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| June 5, 2025 | Cockroft Bettina M. | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 137,404,145 | 9999.99% | 0.04% |
| Feb. 27, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 228225 | $0.00 | 228,225.0000 | 137,404,145 | 9999.99% | 0.17% |
| Feb. 27, 2024 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Common Stock | 44963 | $0.00 | 128,777.0000 | 75,673,081 | 53.65% | 0.06% |
| Feb. 27, 2025 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 272575 | $0.00 | 272,575.0000 | 137,404,145 | 9999.99% | 0.20% |
| Feb. 27, 2024 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Common Stock | 44963 | $0.00 | 78,442.0000 | 75,673,081 | 134.30% | 0.06% |
| Feb. 27, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 44963 | $0.00 | 122,733.0000 | 75,673,081 | 57.82% | 0.06% |
| Feb. 27, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 272575 | $0.00 | 272,575.0000 | 137,404,145 | 9999.99% | 0.20% |
| Feb. 27, 2025 | Love Douglas | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 1300000 | $0.00 | 1,300,000.0000 | 137,404,145 | 9999.99% | 0.95% |
| Feb. 27, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Common Stock | 44963 | $0.00 | 106,200.0000 | 75,673,081 | 73.42% | 0.06% |
| Feb. 27, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Stock Option (Right to Buy) | 272575 | $0.00 | 272,575.0000 | 137,404,145 | 9999.99% | 0.20% |
| Feb. 27, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Common Stock | 44963 | $0.00 | 131,542.0000 | 75,673,081 | 51.93% | 0.06% |
| Feb. 27, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 272575 | $0.00 | 272,575.0000 | 137,404,145 | 9999.99% | 0.20% |
| Feb. 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 6912 | $2.92 | 77,770.0000 | 137,404,145 | 8.16% | 0.01% |
| Feb. 18, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S | Common Stock | 5521 | $2.96 | 33,479.0000 | 137,404,145 | 14.16% | 0.00% |
| Feb. 18, 2025 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S | Common Stock | 5515 | $2.97 | 83,814.0000 | 137,404,145 | 6.17% | 0.00% |
| Feb. 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 8345 | $2.91 | 61,237.0000 | 137,404,145 | 11.99% | 0.01% |
| Feb. 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 6618 | $2.95 | 86,579.0000 | 137,404,145 | 7.10% | 0.00% |
| Feb. 13, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 1783 | $2.99 | 69,582.0000 | 137,404,145 | 2.50% | 0.00% |
| Feb. 13, 2025 | Love Douglas | PRESIDENT AND CEO | S | Common Stock | 5021 | $2.95 | 351,554.0000 | 137,404,145 | 1.41% | 0.00% |
| Feb. 13, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1786 | $2.98 | 84,682.0000 | 137,404,145 | 2.07% | 0.00% |
| Feb. 13, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 1425 | $2.99 | 93,197.0000 | 137,404,145 | 1.51% | 0.00% |
| Jan. 9, 2025 | JONES WILLIAM A JR | Not found | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 137,404,145 | 9999.99% | 0.06% |
| Jan. 6, 2025 | Love Douglas | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 37994 | $0.00 | 0.0000 | 137,404,145 | 100.00% | 0.03% |
| Jan. 6, 2025 | Love Douglas | PRESIDENT AND CEO | M | Common Stock | 37994 | $1.41 | 356,575.0000 | 137,404,145 | 11.93% | 0.03% |
| Dec. 2, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $5.33 | 25,600.0000 | 139,933,019 | 14.29% | 0.00% |
| Oct. 30, 2024 | Love Douglas | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 78399 | $0.00 | 0.0000 | 139,933,019 | 100.00% | 0.06% |
| Oct. 30, 2024 | Love Douglas | PRESIDENT AND CEO | M | Common Stock | 78399 | $1.85 | 274,520.0000 | 139,933,019 | 39.97% | 0.06% |
| Oct. 30, 2024 | Love Douglas | PRESIDENT AND CEO | M | Common Stock | 36050 | $1.85 | 310,570.0000 | 139,933,019 | 13.13% | 0.03% |
| Oct. 30, 2024 | Love Douglas | PRESIDENT AND CEO | M | Stock Option (Right to Buy) | 36050 | $0.00 | 0.0000 | 139,933,019 | 100.00% | 0.03% |
| Oct. 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | M | Stock Option (Right to Buy) | 5408 | $0.00 | 30,646.0000 | 139,933,019 | 15.00% | 0.00% |
| Oct. 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | M | Common Stock | 5408 | $1.85 | 76,773.0000 | 139,933,019 | 7.58% | 0.00% |
| Oct. 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 5408 | $7.41 | 71,365.0000 | 139,933,019 | 7.04% | 0.00% |
| Oct. 1, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $5.97 | 22,400.0000 | 139,933,019 | 16.67% | 0.00% |
| Sept. 19, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 4500 | $7.10 | 71,365.0000 | 75,673,081 | 5.93% | 0.01% |
| Sept. 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 5500 | $6.16 | 75,865.0000 | 75,673,081 | 6.76% | 0.01% |
| Sept. 5, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 5500 | $5.64 | 81,365.0000 | 75,673,081 | 6.33% | 0.01% |
| Sept. 3, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $5.48 | 19,200.0000 | 75,673,081 | 20.00% | 0.00% |
| Aug. 29, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 5500 | $5.95 | 86,865.0000 | 75,673,081 | 5.95% | 0.01% |
| Aug. 1, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $6.24 | 16,000.0000 | 75,673,081 | 25.00% | 0.00% |
| July 15, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 784 | $6.02 | 94,622.0000 | 75,673,081 | 0.82% | 0.00% |
| July 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 1106 | $6.02 | 92,365.0000 | 75,673,081 | 1.18% | 0.00% |
| July 15, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1104 | $6.03 | 86,468.0000 | 75,673,081 | 1.26% | 0.00% |
| July 1, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $5.00 | 12,800.0000 | 75,673,081 | 33.33% | 0.00% |
| June 5, 2024 | Carson William H. | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 5, 2024 | Cockroft Bettina M. | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 5, 2024 | Waddill William D. | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 5, 2024 | Choi Jung | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 5, 2024 | Satter Muneer A | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 5, 2024 | WIGGANS THOMAS G | Not found | A | Stock Option (Right to Buy) | 44000 | $0.00 | 44,000.0000 | 75,673,081 | 9999.99% | 0.06% |
| June 3, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $4.83 | 9,600.0000 | 75,673,081 | 50.00% | 0.00% |
| May 1, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $4.68 | 6,400.0000 | 75,673,081 | 100.00% | 0.00% |
| April 8, 2024 | Carson William H. | Not found | P | Common Stock | 3200 | $6.07 | 3,200.0000 | 75,673,081 | 9999.99% | 0.00% |
| Feb. 16, 2024 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Common Stock | 39000 | $0.00 | 89,329.0000 | 75,673,081 | 77.49% | 0.05% |
| Feb. 16, 2024 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 16, 2024 | Dananberg Jamie | CHIEF MEDICAL OFFICER | A | Common Stock | 39000 | $0.00 | 39,000.0000 | 75,673,081 | 9999.99% | 0.05% |
| Feb. 16, 2024 | Love Douglas | PRESIDENT AND CEO | A | Stock Option (Right to Buy) | 656200 | $0.00 | 656,200.0000 | 75,673,081 | 9999.99% | 0.87% |
| Feb. 20, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 2593 | $5.53 | 82,058.0000 | 75,673,081 | 3.06% | 0.00% |
| Feb. 16, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 20, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 1951 | $5.48 | 85,641.0000 | 75,673,081 | 2.23% | 0.00% |
| Feb. 16, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A | Common Stock | 39000 | $0.00 | 87,592.0000 | 75,673,081 | 80.26% | 0.05% |
| Feb. 16, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 20, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 2604 | $5.51 | 93,471.0000 | 75,673,081 | 2.71% | 0.00% |
| Feb. 16, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | A | Common Stock | 39000 | $0.00 | 96,075.0000 | 75,673,081 | 68.33% | 0.05% |
| Feb. 16, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 16, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | A | Common Stock | 39000 | $0.00 | 84,651.0000 | 75,673,081 | 85.43% | 0.05% |
| Feb. 16, 2024 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 75,673,081 | 9999.99% | 0.21% |
| Feb. 12, 2024 | Love Douglas | PRESIDENT AND CEO | S | Common Stock | 5782 | $5.54 | 196,121.0000 | 75,673,081 | 2.86% | 0.01% |
| Feb. 12, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S | Common Stock | 1809 | $5.54 | 45,651.0000 | 75,673,081 | 3.81% | 0.00% |
| Feb. 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S | Common Stock | 1810 | $5.54 | 57,075.0000 | 75,673,081 | 3.07% | 0.00% |
| Feb. 12, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S | Common Stock | 1349 | $5.53 | 48,592.0000 | 75,673,081 | 2.70% | 0.00% |
| July 11, 2023 | Lew Jennifer | EVP & Chief Financial Officer | S | Common Stock | 1057 | $3.84 | 47,460.0000 | 0 | 2.18% | 0.00% |
| Dec. 27, 2023 | Yednock Ted | EVP & Chief Innovation Officer | M | Common Stock | 10385 | $1.85 | 79,885.0000 | 0 | 14.94% | 0.00% |
| Dec. 27, 2023 | Yednock Ted | EVP & Chief Innovation Officer | S | Common Stock | 21000 | $4.52 | 58,885.0000 | 0 | 26.29% | 0.00% |
| July 11, 2023 | Overdorf Michael | EVP & Chief Business Officer | S | Common Stock | 978 | $3.84 | 45,802.0000 | 0 | 2.09% | 0.00% |
| July 11, 2023 | Yednock Ted | EVP & Chief Innovation Officer | S | Common Stock | 1057 | $3.84 | 58,885.0000 | 0 | 1.76% | 0.00% |
| Dec. 27, 2023 | Yednock Ted | EVP & Chief Innovation Officer | M | Common Stock | 10615 | $1.41 | 69,500.0000 | 0 | 18.03% | 0.00% |